Adenosine A(3) receptor as a novel therapeutic target to reduce secondary events and improve neurocognitive functions following traumatic brain injury

BACKGROUND: Traumatic brain injury (TBI) is a common pathological condition that presently lacks a specific pharmacological treatment. Adenosine levels rise following TBI, which is thought to be neuroprotective against secondary brain injury. Evidence from stroke and inflammatory disease models sugg...

Descripción completa

Detalles Bibliográficos
Autores principales: Farr, Susan A., Cuzzocrea, Salvatore, Esposito, Emanuela, Campolo, Michela, Niehoff, Michael L., Doyle, Timothy M., Salvemini, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659122/
https://www.ncbi.nlm.nih.gov/pubmed/33183330
http://dx.doi.org/10.1186/s12974-020-02009-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659122/
https://www.ncbi.nlm.nih.gov/pubmed/33183330
http://dx.doi.org/10.1186/s12974-020-02009-7

Ejemplares similares